Evidence map›Paper›PMID 42638233›Full record

ArticlePharmaceutical nanotechnology2026

Moringa Peregrina-derived Selenium Nanoparticles: Potent Inhibitor of Key Inflammatory Pathways in Aluminum-exposed Rats.

Toka R Mohei Eldeen, Mohammed A Hussein, Nasser Y Mostafa, Sally M F Abdelsalam

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Toka R Mohei EldeenMedical Labs Department, Faculty of Applied Medical Science, October 6 University, Giza, Egypt.
Mohammed A HusseinDepartment of Biotechnology, Faculty of Applied Health Science Technology, October 6 University, Giza, Egypt.ORCID 0000-0002-1811-2794
Nasser Y MostafaChemistry Department, Faculty of Science, Suez Canal University, Ismailia, Egypt.
Sally M F AbdelsalamChemistry Department, Faculty of Science, Suez Canal University, Ismailia, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman exposure to aluminium, due to its high availability, can lead to nephrotoxicity. This exposure generates reactive oxygen species and triggers apoptosis, contributing to mitochondrial dysfunction and oxidative damage. Moringa peregrina, a plant valued for its traditional, nutritional, industrial, and medicinal properties, has been studied for its pharmacological benefits. Selenium nanoparticles synthesized using plant extracts have garnered attention for their potential medicinal importance.

objectiveThis study aims to investigate the nephroprotective effects of Moringa peregrinaselenium nanoparticles (MPE-SeNPs) on aluminium-induced renal injury.

methodsDried powdered seeds of M. peregrina (100 g) were extracted in distilled water to evaluate total phenolics and flavonoids and prepare the targeted MPE-SeNPs. These nanoparticles were characterized using TEM, UV-Vis, and FTIR. The LD RESULTS AND DISCUSSION: The phenolic and flavonoid content of Moringa peregrina was approximately 76.42 mg of GAE/g DE and 15.55 mg of QE/g DE, respectively. TEM analysis showed that the nanoparticles had a size of around 64.5 ± 5.5 nm with a zeta potential value of 28.57 mV. The UV-Vis profile of the nanoparticles showed two specific peaks at 268 and 277 nm. At the same time, FTIR spectral data revealed the presence of OH, CH-arom., CH-aliph., and C=O groups, characterizing phenolics and flavonoids. The LD50 of the nanoparticles was 773 mg/kg b.w. Oral administration of M. peregrina extract (150 mg) and MPE-SeNPs (15.46 and 38.65 mg/kg b.w.) daily for 7 days significantly improved blood selenium levels as well as plasma levels of urea, creatinine, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), and phospholipids, as well as renal malondialdehyde (MDA), reduced glutathione (GSH), superoxide dismutase (SOD), glutathione reductase (GR), interleukin-2 (IL-2), interleukin-4 (IL-4), and interleukin-10 (IL-10) in aluminium-intoxicated rats. Furthermore, M. peregrina and its selenium nanoparticles downregulated renal transforming growth factor-β1 (TGF-β1), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF-α) gene expression in aluminium-exposed rats. The antioxidant and anti-inflammatory activity in rats treated with MPE-SeNPs was more pronounced than in those treated with M. peregrina extract alone. Histopathological results indicated that MPE-SeNPs improved renal tissue by enhancing antioxidant enzymes and anti-inflammatory cytokines (IL-4 and IL-10), suppressing pro-inflammatory IL-2, and scavenging free radicals.

conclusionThe seeds of M. peregrina are rich in phenolic compounds, including flavonoids, glucosides, and glucosinolates. MPE-SeNPs show promise as a protective agent against aluminiuminduced renal injury, with their ability to mitigate oxidative stress, inflammation, and apoptosis underscoring their potential therapeutic value.

Indexed as

AluminumInflammationKidney DiseasesMoringaNanoparticlesPlant ExtractsSeleniumAnimalsAntioxidantsFlavonoidsKidneyMaleOxidative StressRatsRats, WistarSeedsAluminumAntioxidantsFlavonoidsPlant ExtractsSeleniumaluminum toxicitycytokine regulationMoringa peregrinaoxidative stressrenal toxicityselenium nanoparticles

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.